Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
The Los Angeles-based Tradewinds Global Investors now holds 580,494 shares in Egis, reaching a 7.456% stake in the Hungarian pharmaceutical company, Egis announced on Thursday.
The stake held by Tradewinds Global Investors surpassed the 5% limit requiring a public announcement on June 24. The announcement did not reveal the stake the US investor held before the transaction only said that it was below the 5% limit.
Egis is majority owned by Servier group of France which held 50.91% of the shares on March 1 this year. The only other owner with a stake in excess of 5% on March 1 was FTIF Templeton Eastern Europe Fund, holding 5.76% of the shares.